Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Nexus NeuroTech Ventures is a venture capital firm founded in 2023 and based in San Francisco. The firm focuses on advancing technologies for brain disorders, including neurodegenerative, neuropsychiatric, and neurodevelopmental conditions. They are in the early stages of operations and are actively building their portfolio.
Nexus NeuroTech Ventures invests in a variety of technologies and services aimed at addressing brain disorders. Their investment areas include software and data platforms, therapy developers, diagnostic technology, medical devices, and research tools. They make investments across seed and series A-C stages and support early-stage programs through the Nexus NeuroTech Incubator Program.
Nexus NeuroTech Ventures has begun building its portfolio, which includes notable companies such as Ampa Health, developing scalable brain stimulation technology; Beacon Biosignals, focused on unlocking sleep data; and Cala Health, creator of an FDA-cleared wearable device for treating tremors. Other companies in their portfolio include Cortica, Insightec, Lotus Neuro, and Synapticure.
Email info@nexusneurotech.com with your deck to pitch Nexus NeuroTech Ventures.
Nexus NeuroTech Ventures operates the Nexus NeuroTech Incubator Program, which supports early-stage programs focused on brain health technologies. Interested startups can apply through their website.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.